SAN CLEMENTE, CA--(Marketwired - April 24, 2013) - Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that it will attend this year's Food Safety Summit Conference and exhibit the MIT 1000 in Baltimore, Maryland -- April 30 through May 2, 2013. Now in its 15th year, the Food Safety Summit provides important food safety information and solutions to those responsible for assuring food safety across the food supply chain.
The Food Safety Summit is a solutions-based conference and expo designed to meet the educational and information needs of the entire food industry including growers, processors, retailers, distributors, foodservice operators, regulators and academia. "We will continue to showcase the MIT 1000 to the Food Safety Industry through these events," stated Jeff Nunez, MIT's Chairman and CEO. "Our primary objective, dedication, and commitment, however, is to the development of additional 'Identifiers.' In the meantime, it is important that we continue to expose the Food Safety Industry and begin showing the Clinical Industry the speed, ease of use, accuracy, and low cost of the MIT 1000 System, which can be commercially used today for the pathogenic testing of Listeria species." Please visit us at Booth #610.
The MIT 1000 is a stand-alone, rapid laser based bacteria detection and identification technology; a software driven system that can detect pathogenic bacteria and complete an identifying test in under three (3) minutes (average) at significant cost savings per test. In June 2009, the AOAC Research Institute (AOAC RI) awarded the Company Performance Tested Methods SM (PTM) certification for the rapid identification of Listeria. The AOAC RI provides an independent third party evaluation and expert reviews of methods and will award PTM certification to methods that demonstrate performance levels equivalent or better than other certified bacteria identifying methods. The MIT System underwent hundreds of individual tests, including ruggedness and accuracy, to earn AOAC RI's certification for the identification of Listeria.
About: Micro Imaging Technology, Inc.
Micro Imaging Technology, Inc. is a California-based public company that is also registered to do business under the name Micro Identification Technologies. MIT has developed and patented the MIT-1000, a stand-alone, optically-based, software driven system that can detect pathogenic bacteria and complete an identification test, after culturing, in less than three (3) minutes (average) at the lowest cost per test when compared to any other conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process requires only clean particle-free water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion, which is expected to surpass $4.7 billion by 2015 according to BCC Research. In addition, the recently passed "New" U.S. Food Safety Bill is expected to further accelerate the current annual growth rate of 6.6 percent.
You can find more information about our company and about Micro Identification Technologies™. Please visit our newly enhanced website at www.micro-identification.com.
This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission, reference MMTC: www.sec.gov.